Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Ratios and Metrics

Market cap in millions EGP. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	3,827	2,676	997	637	551	539
Market Cap Growth	163.56%	168.26%	56.67%	15.47%	2.38%	25.17%
Enterprise Value	3,777	2,740	1,128	710	475	432
Last Close Price	256.23	168.55	55.89	33.04	25.22	22.22
PE Ratio	7.46	6.03	4.05	6.56	3.33	4.33
PS Ratio	1.66	1.29	0.73	0.63	0.50	0.51
PB Ratio	3.25	2.56	1.20	0.94	0.69	0.77
P/TBV Ratio	3.25	2.56	1.20	0.94	0.70	0.77
P/FCF Ratio	13.03	11.18	21.38	67.35	15.98	3.89
P/OCF Ratio	8.95	7.07	3.79	7.19	10.64	3.32
EV/Sales Ratio	1.63	1.32	0.83	0.71	0.43	0.41
EV/EBITDA Ratio	5.42	4.57	3.88	8.04	2.29	2.76
EV/EBIT Ratio	5.76	4.83	3.95	9.26	2.47	2.76
EV/FCF Ratio	12.86	11.45	24.19	75.14	13.76	3.12
Debt / Equity Ratio	0.16	0.21	0.28	0.24	0.07	-
Debt / EBITDA Ratio	0.27	0.37	0.82	1.77	0.28	-
Debt / FCF Ratio	0.65	0.93	5.09	17.38	1.69	-
Asset Turnover	1.13	1.17	0.99	0.84	0.99	1.03
Inventory Turnover	3.09	2.44	1.94	2.09	2.56	2.59
Quick Ratio	0.88	0.98	1.17	1.05	1.90	1.77
Current Ratio	1.68	1.83	2.25	2.21	3.08	2.56
Return on Equity (ROE)	49.27%	47.23%	32.54%	13.17%	22.13%	18.31%
Return on Assets (ROA)	20.12%	20.04%	12.96%	3.98%	10.73%	9.50%
Return on Invested Capital (ROIC)	45.70%	43.88%	27.75%	8.08%	21.94%	21.11%
Return on Capital Employed (ROCE)	48.30%	46.20%	27.30%	9.70%	22.40%	22.00%
Earnings Yield	13.41%	16.58%	24.67%	15.25%	30.06%	23.08%
FCF Yield	7.67%	8.94%	4.68%	1.49%	6.26%	25.73%
Dividend Yield	6.61%	9.93%	22.95%	15.13%	19.83%	18.00%
Payout Ratio	48.73%	49.76%	34.75%	103.84%	45.37%	62.53%
Total Shareholder Return	6.50%	9.93%	22.95%	15.13%	19.83%	18.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.